INGN

Health Care Sector Update for 02/15/2024: INGN

Health care stocks rose late Thursday afternoon, with the NYSE Health Care Index adding 0.4% and the Health Care Select Sector SPDR Fund (XLV) gaining 0.7%.

The iShares Biotechnology ETF (IBB) climbed 1.1%.

In corporate news, Inogen (INGN) shares jumped nearly 20% after William Blair upgraded the company to outperform from market perform.

Aurinia Pharmaceuticals (AUPH) tumbled 24% after the company's Q4 loss widened more than expected and a strategic review ended with only one non-binding expression of interest, which didn't result in a formal offer.

Alkermes (ALKS) surged 16% after the firm reported Q4 non-GAAP earnings of $0.22 per share, up from $0.14 a year ago.

West Pharmaceutical Services (WST) plunged 14% after its 2024 guidance for adjusted earnings and net sales missed market expectations.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.